WDNA stock forecast, quote, news & analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), ZOETIS (NYSE:ZTS), Dow (NYSE:DOW).

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

The average market capitalization across the WisdomTree BioRevolution ETF ETF is 42.81B. The market cap for tickers in the group ranges from 64.65K to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is BAYN at 64.65K.

The average weekly price growth across all stocks in the WisdomTree BioRevolution ETF ETF was 12%. For the same ETF, the average monthly price growth was 41%, and the average quarterly price growth was 101%. NTRA experienced the highest price growth at 4%, while DNA experienced the biggest fall at -26%.

The average weekly volume growth across all stocks in the WisdomTree BioRevolution ETF ETF was -26%. For the same stocks of the ETF, the average monthly volume growth was 36% and the average quarterly volume growth was 41%